Onderneming DelMar Pharmaceuticals Inc Nasdaq
Aandelen
US2470782077
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11-04-18 |
Greg Johnson
COO | Chief Operating Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hoffman
CEO | Chief Executive Officer | 58 | 11-04-18 |
Tamara Favorito
BRD | Director/Board Member | 65 | 29-04-21 |
Laura Douglass
BRD | Director/Board Member | 59 | 26-06-20 |
Robert Toth
BRD | Director/Board Member | 60 | 20-08-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 14 000 | 0 | 0 | 99,81 % |
Aandeel B | 1 | 39 037 899 | 38 961 784 ( 99,81 %) | 0 | |
Aandeel C | 0 | 279 000 | 0 | 0 |
Bedrijfsgegevens
Kintara Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 150
92121, San Diego
+858 350 4364
http://www.kintara.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,44% | 106 mld. | |
+0,82% | 104 mld. | |
+6,72% | 23,25 mld. | |
-13,89% | 22,5 mld. | |
-6,64% | 18,7 mld. | |
-37,26% | 17,95 mld. | |
-10,98% | 16,99 mld. | |
+8,67% | 14,26 mld. | |
+41,08% | 12,76 mld. |